161 related articles for article (PubMed ID: 35018481)
1. Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.
Femel J; van Hooren L; Herre M; Cedervall J; Saupe F; Huijbers EJM; Verboogen DRJ; Reichel M; Thijssen VL; Griffioen AW; Hellman L; Dimberg A; Olsson AK
Cancer Immunol Immunother; 2022 Aug; 71(8):2029-2040. PubMed ID: 35018481
[TBL] [Abstract][Full Text] [Related]
2. Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
Bannoud N; Stupirski JC; Cagnoni AJ; Hockl PF; Pérez Sáez JM; García PA; Mahmoud YD; Gambarte Tudela J; Scheidegger MA; Marshall A; Corrie PG; Middleton MR; Mariño KV; Girotti MR; Croci DO; Rabinovich GA
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2214350120. PubMed ID: 36634146
[TBL] [Abstract][Full Text] [Related]
3. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.
Croci DO; Cerliani JP; Dalotto-Moreno T; Méndez-Huergo SP; Mascanfroni ID; Dergan-Dylon S; Toscano MA; Caramelo JJ; García-Vallejo JJ; Ouyang J; Mesri EA; Junttila MR; Bais C; Shipp MA; Salatino M; Rabinovich GA
Cell; 2014 Feb; 156(4):744-58. PubMed ID: 24529377
[TBL] [Abstract][Full Text] [Related]
5. Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders.
Ouyang J; Juszczynski P; Rodig SJ; Green MR; O'Donnell E; Currie T; Armant M; Takeyama K; Monti S; Rabinovich GA; Ritz J; Kutok JL; Shipp MA
Blood; 2011 Apr; 117(16):4315-22. PubMed ID: 21300977
[TBL] [Abstract][Full Text] [Related]
6. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
7. Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice.
Shu C; Sun P; Xie H; Huang W; Qi J; Ma Y
Int J Nanomedicine; 2020; 15():1983-1996. PubMed ID: 32308382
[TBL] [Abstract][Full Text] [Related]
8. Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease.
Dalotto-Moreno T; Croci DO; Cerliani JP; Martinez-Allo VC; Dergan-Dylon S; Méndez-Huergo SP; Stupirski JC; Mazal D; Osinaga E; Toscano MA; Sundblad V; Rabinovich GA; Salatino M
Cancer Res; 2013 Feb; 73(3):1107-17. PubMed ID: 23204230
[TBL] [Abstract][Full Text] [Related]
9. CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposes against a murine melanoma.
Jellbauer S; Panthel K; Hetrodt JH; Rüssmann H
PLoS One; 2012; 7(4):e34214. PubMed ID: 22511934
[TBL] [Abstract][Full Text] [Related]
10. OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis.
Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Rabinovich GA; Bieche I; Vidaud M; de Gramont A; Martinet M; Cvitkovic E; Faivre S; Raymond E
Eur J Cancer; 2014 Sep; 50(14):2463-77. PubMed ID: 25042151
[TBL] [Abstract][Full Text] [Related]
11. Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells.
Manzi M; Bacigalupo ML; Carabias P; Elola MT; Wolfenstein-Todel C; Rabinovich GA; Espelt MV; Troncoso MF
J Cell Physiol; 2016 Jul; 231(7):1522-33. PubMed ID: 26551914
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma.
Pranjol MZI; Zinovkin DA; Maskell ART; Stephens LJ; Achinovich SL; Los' DM; Nadyrov EA; Hannemann M; Gutowski NJ; Whatmore JL
J Transl Med; 2019 Jul; 17(1):216. PubMed ID: 31269957
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.
Prins RM; Bruhn KW; Craft N; Lin JW; Kim CH; Odesa SK; Miller JF; Liau LM
Neurosurgery; 2006 Jan; 58(1):169-78; discussion 169-78. PubMed ID: 16385341
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
[TBL] [Abstract][Full Text] [Related]
15. Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions.
Bonzi J; Bornet O; Betzi S; Kasper BT; Mahal LK; Mancini SJ; Schiff C; Sebban-Kreuzer C; Guerlesquin F; Elantak L
Nat Commun; 2015 Feb; 6():6194. PubMed ID: 25708191
[TBL] [Abstract][Full Text] [Related]
16. Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy.
Elia AR; Grioni M; Basso V; Curnis F; Freschi M; Corti A; Mondino A; Bellone M
Clin Cancer Res; 2018 May; 24(9):2171-2181. PubMed ID: 29490991
[No Abstract] [Full Text] [Related]
17. Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report.
Aris M; Bravo AI; Pampena MB; Blanco PA; Carri I; Koile D; Yankilevich P; Levy EM; Barrio MM; Mordoh J
Front Immunol; 2018; 9():955. PubMed ID: 29774030
[TBL] [Abstract][Full Text] [Related]
18. Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma.
Ouyang J; Plütschow A; Pogge von Strandmann E; Reiners KS; Ponader S; Rabinovich GA; Neuberg D; Engert A; Shipp MA
Blood; 2013 Apr; 121(17):3431-3. PubMed ID: 23444403
[TBL] [Abstract][Full Text] [Related]
19. A short hairpin RNA-based adjuvant targeting NF-κB repressor IκBα promotes migration of dermal dendritic cells to draining lymph nodes and antitumor CTL responses induced by DNA vaccination.
Gálvez-Cancino F; Roco J; Rojas-Colonelli N; Flores C; Murgas P; Cruz-Gómez S; Oyarce C; Varas-Godoy M; Sauma D; Lladser A
Vaccine; 2017 Jul; 35(33):4148-4154. PubMed ID: 28666759
[TBL] [Abstract][Full Text] [Related]
20. A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival.
Sharbi-Yunger A; Grees M; Cafri G; Bassan D; Eichmüller SB; Tzehoval E; Utikal J; Umansky V; Eisenbach L
Int J Cancer; 2019 Feb; 144(4):909-921. PubMed ID: 30106470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
